Salesforce.com, inc.(CRM.US): The AI Narrative Mismatch That May Handed Value Investors a Gift

1. Valuation & Drawdown Snapshot

• Recent Drawdown: Salesforce has declined approximately 26% year-to-date in 2026, with shares sliding from roughly $265 at year-end 2025 to the $195 range as of March 11, 2026
• Valuation Level: The stock now trades at a trailing P/E of approximately 25x — a dramatic compression from its three-year historical average of 132x. This places current valuation in roughly the bottom 3rd percentile of the company's own historical range. Forward P/E has compressed to approximately 14x based on FY2027 EPS guidance of $13.11–$13.19
• Peer Comparison: ServiceNow declined 36% over the same period, HubSpot fell 51%, and Monday.com dropped 44% — Salesforce's relative drawdown is actually shallower than many SaaS peers, yet it carries the largest enterprise moat in the group

2. The Mispricing: What the Market Got Wrong

What triggered the selloff: The decline was driven by fear of AI disrupting the traditional seat-based SaaS model — not by any measurable deterioration in Salesforce's actual business. Specific catalysts included the circulation of a widely-shared Citrini Research blog post describing a dystopian 2028 scenario for software employment, the release of Anthropic's Claude Code tool for software development, and a broader sector-wide derating.

Why we believe the market overreacted:

• Core Business Intact — The $72B Backlog Doesn't Lie: Salesforce ended FY2026 with total remaining performance obligations of $72.4 billion, up 14% year-over-year. This figure represents contracted, signed customer commitments — enterprises are not fleeing Salesforce. The company that customers are supposedly abandoning due to AI actually has more revenue contractually locked in than ever before
• Agentforce Is the Answer to AI Disruption, Not the Victim: Agentforce ARR grew 169% year-over-year to $800 million as of Q4 FY2026, with the combined Agentforce + Data Cloud ARR exceeding $1.4 billion at 114% year-over-year growth. In the first 15 months since launch, Salesforce closed over 29,000 Agentforce deals. The narrative that AI kills CRM ignores that Salesforce has repositioned itself as an AI agent deployment platform — the very infrastructure enterprises need to operationalize AI
• Management Is Putting Its Balance Sheet Behind the Thesis: CEO Marc Benioff authorized a new $50 billion share repurchase program, stating plainly that current prices represent "some low prices." The company returned over $14 billion to shareholders in FY2026, equivalent to approximately 99% of free cash flow. Boards do not authorize $50B buybacks when they believe their business is structurally impaired

Institutional Validation:

• JPMorgan: Overweight | Target: $320 | Maintains conviction on Agentforce early-stage adoption signals and AI-agent monetization potential
• Needham: Buy | Target: $400 (unchanged through the selloff) | cRPO exceeding guidance, Agentforce commercialization accelerating on schedule

3. Value Anchors & Ongoing Coverage

Watch Signal (Left-Side / Right-Side): Left-side zone is the current $190–205 range, defined by the 14x forward P/E floor — a multiple more appropriate for a structurally declining business than for a company growing revenue 10%+ with $72B in contracted backlog. Right-side confirmation would be a Q1 FY2027 cRPO print above 12%, which management has guided for approximately 14% — that would signal the Agentforce ramp is becoming visible in the contracted revenue pipeline. Watch for the cRPO figure specifically, not just headline revenue, as it is the cleanest leading indicator of future revenue acceleration.

Thesis Invalidation Triggers (know when to be proven wrong):

• If Q1 FY2027 cRPO growth falls below 10% — this would confirm that AI disruption is reducing contract values, breaking the entire growth reacceleration thesis
• If two consecutive quarters show negative year-over-year revenue in Sales Cloud or Service Cloud — this would signal genuine customer loss rather than investor panic, and the structural bear case takes over

Next Tracking Checkpoint: Q1 FY2027 earnings report — expected late May 2026. The cRPO figure and Agentforce ARR will be the two numbers that matter most. This column will publish a follow-up review at that time.

⚠️ Risk Disclosure: This analysis is for informational purposes only and does not constitute investment advice. All data sourced from publicly available institutional research and company filings. Past performance does not guarantee future results.

BlackRock, Inc.(BLK.US): When 0.19% of AUM Triggers a 15% Stock Decline, Someone May Has the Math Wrong

1. Valuation & Drawdown Snapshot

• Recent Drawdown: BlackRock declined approximately 15–16% over the past two weeks. The stock dropped 7% on March 6 following the HPS fund withdrawal news (Seeking Alpha; Investing.com), and at one point fell an additional 3% on March 9 as selling pressure persisted.
• Valuation Level: At approximately $950 range, BlackRock trades at roughly 30x trailing earnings and approximately 19.5x forward earnings. The average analyst price target across 15 covering analysts stands at approximately $1,260–1,317, implying 31–37% upside from current levels. The RSI registered ~27 — deep in oversold territory — as of March 9
• Peer Comparison: Apollo, KKR, Carlyle, Ares, and Blue Owl all declined 5–6% on the same catalyst. BlackRock's 15%+ cumulative drawdown substantially exceeds these peers — who have far greater private credit exposure as a percentage of their total business — suggesting the market is mispricing BlackRock's actual risk profile relative to pure-play alternatives managers

2. The Mispricing: What the Market Got Wrong

What triggered the selloff: On March 6, Bloomberg and the Wall Street Journal reported that BlackRock's $26 billion HPS Corporate Lending Fund had capped investor withdrawals after redemption requests reached 9.3% of shares — exceeding the fund's 5% quarterly repurchase limit. The resulting approximately $620 million repurchase represented less than the $1.2 billion investors sought. The news triggered a 7% single-day decline and ignited broader fears of a systemic private credit liquidity crisis.

Why we believe the market overreacted:

• The Affected Fund Represents 0.19% of BlackRock's Total AUM: The $26 billion HPS Corporate Lending Fund exists within BlackRock's alternatives segment, which accounts for approximately 5% of the firm's $14.041 trillion in total AUM. The core of BlackRock's business — the iShares ETF platform, passive index strategies, and institutional fixed income — has zero structural exposure to private credit liquidity constraints. The market applied a private-credit-manager discount to a company whose business model is overwhelmingly built on liquid, fee-generating passive strategies
• This Was the Fund Working as Designed, Not a Crisis Signal: BlackRock explicitly stated the withdrawal cap "aligns with existing liquidity management for the fund and represents a foundational feature." This is a standard non-traded BDC mechanism, not an emergency gating. The alternative — honoring all $1.2 billion in redemptions — would have required forced asset sales in an illiquid market, which would have been the actual crisis. Blackstone, facing similar dynamics in its BCRED fund, voluntarily raised its withdrawal limit to 7% — illustrating there is no industry consensus on "right," only different risk management philosophies
• The Core Business Is Accelerating, Not Deteriorating: Q4 2025 earnings delivered EPS of $13.16, beating the $12.55 consensus, with revenue growing 23.4% year-over-year to $7.01 billion. BlackRock then raised its quarterly dividend to $5.73 per share — a 10% increase from $5.21 — at the same moment the private credit scare was unfolding. A 10% dividend increase is not the act of a management team concerned about the health of its underlying business

Institutional Validation:

• Morgan Stanley: Overweight | Target: $1,550 | ETF platform structural pricing power; AUM growth compound; alternatives platform still early-stage
• Evercore: Outperform (maintained post-event, price target trimmed only) | Private credit event is isolated; fee income growth trajectory intact

3. Value Anchors & Ongoing Coverage

Watch Signal (Left-Side / Right-Side): Left-side as of the current $940–980 range, where the stock sits approximately 15% below its 50-day moving average and RSI indicates severely oversold conditions. BlackRock's beta of 1.48 means any resolution of the U.S.-Iran conflict — which has been a meaningful macro overhang since late February — may generate amplified upside. Right-side confirmation comes from the Q1 2026 earnings report, specifically the net AUM flow data for the ETF business. If core iShares net flows remain positive despite the private credit headlines, the thesis is cleanly validated.

Thesis Invalidation Triggers (know when to be proven wrong):

• If Q1 2026 earnings show that the private credit scare has triggered net outflows from BlackRock's core ETF or institutional products — meaning reputational contagion has reached the main business — the isolated-event thesis fails
• If BlackRock is forced to extend withdrawal caps to additional fund vehicles beyond the HPS Corporate Lending Fund, the systemic risk interpretation gains credibility and the position should be exited

Next Tracking Checkpoint: Q1 2026 earnings report — expected mid-April 2026. The key metric is not earnings per share but net AUM flows across the ETF and institutional platforms. This column will publish a follow-up review at that time.

⚠️ Risk Disclosure: This analysis is for informational purposes only and does not constitute investment advice. All data sourced from publicly available institutional research and company filings. Past performance does not guarantee future results.